BACKGROUND: In some patients with Churg-Strauss syndrome (CSS), especially those
with myocardial or neural involvement, conventional treatment with corticosteroids with or …

Despite standard treatment with systemic corticosteroids and/or antifungal triazoles, a substantial
proportion of patients with allergic bronchopulmonary aspergillosis (ABPA) experience …

Background: Churg-Strauss syndrome (CSS) is a rare systemic necrotizing vasculitis that
develops in some asthma patients. What types of asthma make patients prone to develop this …

Purpose Eosinophilic granulomatosis with polyangiitis (EGPA), a rare disease characterized
by the presence of allergic granulomatosis and necrotizing vasculitis, is often effectively …

… Naomi Tsurikisawa … Naomi Tsurikisawa … Correspondence to Naomi Tsurikisawa. …

Objective. We investigated the risk factors for relapse or prognosis of eosinophilic granulomatosis
with polyangiitis (EGPA) in Japanese patients presenting to our hospital. Methods. …

BACKGROUND: Chronic eosinophilic pneumonia (CEP) with asthma precedes the onset of
Churg-Strauss syndrome (CSS) in half of all patients with CSS. It is not known what …

BACKGROUND: CD203c is a basophil cell surface marker used to diagnose and monitor
various allergic diseases, but its relationship to asthma is not clear. OBJECTIVE: We …

Objective. We studied the effects of intravenous immunoglobulin (IVIG) treatment on clinical
symptoms and regulatory T (Treg) cell frequency in patients with eosinophilic …

Background: In some patients with eosinophilic granulomatosis with polyangiitis (EGPA),
remission cannot be induced, despite treatment with corticosteroids and immunosuppressants. …